Interestingly, the activation of mTOR pathway is also seen in the repeated TLR-9 model, and rapamycin significantly ameliorates MAS symptoms (cytopenia, hyperferritinemia, hepatosplenomegaly, and plasma IFN-γ levels) [72]. Here, MTOR is linked to macrophage activation syndrome.